Antineoplastics

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

 Molecularly targeted agents
   Interleukin 2 receptor toxin
   Monoclonal antibody
   mTOR kinase inhibitor
   Proteosome inhibitor
   Receptor tyrosine kinase inhibitor
     Imatinib [DG:DG00710]
     Gefitinib
     Erlotinib [DG:DG00711]
       D07907  Erlotinib (INN)
       D04023  Erlotinib hydrochloride (JAN/USAN)
     Sunitinib [DG:DG00712]
     Sorafenib [DG:DG00713]
     Dasatinib [DG:DG00714]
     Lapatinib [DG:DG00715]
     Nilotinib [DG:DG00716]
     Pazopanib
     Crizotinib
     Axitinib
     Ruxolitinib [DG:DG00719]
   Retinoic acid receptor expression modification
   Other
 
 Hormones and hormone antagonists
 
 Biologic response modifiers
 
 Alkylating agents
 
 Antimetabolites
 
 Natural products
 
 Miscellaneous agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 22, 2014

» Japanese version